Wed. Jul 24th, 2024


  • Mexican scientists have developed a technology to improve glucose control and detect kidney damage in diabetes patients.
  • The innovation detects glycosylated hemoglobin in blood and other substances in plasma and urine for diabetes control.

Mexican scientists have created a technology to enhance glucose control and early detection of kidney damage in response to the country’s diabetes epidemic. The innovation, developed by scientists from the National Polytechnic Institute and the Research Center for Advanced Studies, allows for the determination of glycosylated hemoglobin and substances associated with kidney damage in people with diabetes. This method uses a minimal amount of blood and does not require toxic substances like potassium cyanide, unlike conventional methods. Guadalupe Cleva Villanueva L√≥pez, the lead researcher on the project, emphasized the importance of detecting glycosylated hemoglobin, creatinine, urea, and proteins to improve diabetes metabolic control and prevent kidney failure.

Alfredo Cruz Orea, a physicist at the Cinvestav, highlighted the technology’s ability to detect elements in the blood spectrum indicating diabetes and kidney damage. The new diagnostic method will undergo analysis by the Federal Commission for Protection against Health Risks for potential health registration. About 12.8 million people in Mexico are affected by diabetes, which can cause damage to organs such as the heart, blood vessels, eyes, kidneys, and nerves. This technology offers a promising advancement in diabetes management and early detection of complications.